Lonneke van der Werf TV Academy
Lucca L.M. Derks, Inge Van Der Werf, Laurianne Trabut, Eline Bertrums, Jurrian De Kanter, Axel Rosendahl Huber, Ruben Van Boxtel; Single-Cell Whole-Genome Sequencing after Chemotherapeutic Treatment Reveals Cell Type-Specific Mutational Burdens. Blood 2023; 142 (Supplement 1):.
Inge van der Werf op LinkedIn ASH 2021 Máxima research into childhood blood cancers
Bernadette A Chua 1 , Inge Van Der Werf 2 , Catriona Jamieson 3 , Robert A J Signer 4 Affiliations 1 Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California San Diego, La Jolla, CA, 92093 USA.
Andrien van der Werf LinkedIn
Inge M. van der Werf's 6 research works with 16 citations and 364 reads, including: Supplementary Figure 5 Inge M. van der Werf's research while affiliated with Amsterdam University Medical Center.
Inge van den Berg Business Unit Manager (PMCleider) Construction Management Witteveen+Bos
Inge van der Werf Expand search. This button displays the currently selected search type. When expanded it provides a list of search options that will switch the search inputs to match the current.
Prinses Máxima Centrum Research
Contact Connect with experts in your field Join ResearchGate to contact this researcher and connect with your scientific community. Join for free Log in About Network About Introduction My name is.
mr. J.P. (Jildou) van der Werf TRIP Advocaten Notarissen
Inge Van Der Werf's research while affiliated with University of California and other places Overview What is this page? This page lists the scientific contributions of an author, who either does.
Hanneke van der Werf, D66 ‘Den Haag profiteert ervan als raadsleden in de Kamer komen’
Inge van der Werf Stem Cell Research at the Division of Regenerative Medicine, Department of Medicine, and Sanford Stem Cell Institute, UC San Diego 9m Report this post I am pleased to announce.
Inge van der Wurff, Open Universiteit Heerlen YouTube
Phoebe Mondala, Inge Van Der Werf, Larisa Balaian, Kathleen Steel, Luisa Ladel, Cayla Mason, Raymond Diep, Jacqueline Cloos, Gertjan Kaspers, Markus J van Roosmalen, Ruben Van Boxtel, Warren Chan, Adam Mark, Mary Donohoe, James La Clair, Peggy Wentworth, Kathleen Fisch, Leslie A Crews, Thomas Whisenant, Michael Burkart, Catriona Jamieson.
S.P. van der Werf
Purpose: Infant acute lymphoblastic leukemia (ALL) is characterized by a high incidence of KMT2A gene rearrangements and poor outcome. We evaluated the value of minimal residual disease (MRD) in infants with KMT2A-rearranged ALL treated within the Interfant-06 protocol, which compared lymphoid-style consolidation (protocol IB) versus myeloid-style consolidation (araC, daunorubicin, etoposide.
Inge van Adrichem Lelystad, Flevoland, Nederland professioneel profiel LinkedIn
Anna Wojtuszkiewicz 1 , Inge van der Werf 1 , Stephan Hutter 2 , Wencke Walter 2 , Constance Baer 2 , Wolfgang Kern 2 , Jeroen J W M Janssen 1 , Gert J Ossenkoppele 1 , Claudia Haferlach 2 , Jacqueline Cloos 1 , Torsten Haferlach 2
Inge van der Heijden Alles wat je moet weten over deze wielrenner
Inge van der Werf on LinkedIn: Detection and targeting of splicing deregulation in pediatric acute… Inge van der Werf's Post Postdoctoral Research Fellow bij Prinses Máxima Centrum voor.
Inge van Calkar 2016 door Willem van der Werf Bogdike Veendam
Inge Van Der Werf, Kathleen Steel, Phoebe Mondala, Larissa Balaian, Jacqueline Cloos, Gertjan J.L. Kaspers, James La Clair, Peggy Wentworth, Kathleen Fisch, Leslie Crews, Thomas Whisenant, Michael Burkart, Mary Donohoe, Catriona Jamieson; Decreased Embryonic Splicing Repressor Expression Enhances Splicing Modulator Sensitivity in Pediatric.
Staff NIMD
Inge van der Werf - Director of Biorepository - Staff Researcher - UC San Diego | LinkedIn Inge van der Werf Stem Cell Research at the Division of Regenerative Medicine, Department of Medicine,.
Peter Tuinman met partner Inge van der Werf_DSC8194.jpg Dutch Press Photo Agency
February 16, 2023 | Researchers at University of California San Diego School of Medicine, Sanford Stem Cell Institute and Moores Cancer Center report that a late-stage, pre-clinical small molecule inhibitor, called rebecsinib, reverses malignant hyper-editing by an inflammation-induced protein isoform, known as ADAR1 p150.
Inge van Duren Teamlead inside Sales ICS Cool Energy LinkedIn
Inge van der Werf's Post Inge van der Werf Stem Cell Research at the Division of Regenerative Medicine, Department of Medicine, and Sanford Stem Cell Institute, UC San Diego
Inge van Calkar 2016 door Willem van der Werf Bogdike Veendam
Leslie A Crews 1 , Wenxue Ma 2 , Luisa Ladel 2 , Jessica Pham 2 , Larisa Balaian 1 , S Kathleen Steel 2 , Phoebe K Mondala 2 , Raymond H Diep 2 , Christina N Wu 2 , Cayla N Mason 2 , Inge van der Werf 2 , Isabelle Oliver 2 , Eduardo Reynoso 2 , Gabriel Pineda 2 , Thomas C Whisenant 3 , Peggy Wentworth 2 , James J La Clair 4 , Qingfei Jiang 2.